Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
Primary tumor removal by cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma patients has been investigated in the context of various treatment regimens. Two randomized controlled trials i...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Laura Iisager, Johanne Ahrenfeldt, Frede Donskov, B örje Ljungberg, Axel Bex, Lars Lund, Iben Lyskjær and Niels Fristrup Tags: Study Protocol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Study